AAAAAA
Results:
1-19
|
Results: 19
Authors:
Pan, Y
Citation: Y. Pan, Functional genomics, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 1-8
Authors:
Huang, Z
Zhao, J
Citation: Z. Huang et J. Zhao, In vitro selection of ligand-binding and catalytic RNA and DNA, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 9-31
Authors:
Guo, ZH
Citation: Zh. Guo, Phage display: A powerful tool in biomedical research, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 32-58
Authors:
Zhou, AM
Citation: Am. Zhou, Advancement of automation and biotechnology in the clinical laboratory: Blood gas, chemiluminescence immunoassay, and nucleic acid diagnostics, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 59-77
Authors:
Zhou, Z
Ng, PC
Citation: Z. Zhou et Pc. Ng, Advantages of replacing the total PSA assay with a complexed PSA assay forthe screening and monitoring of prostate cancer, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 78-84
Authors:
Guo, M
Tian, QP
Tao, JH
Citation: M. Guo et al., Recent advances in organic chemistry related to process research and development, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 85-106
Authors:
Cai, DW
Chen, CY
Shi, YJ
Citation: Dw. Cai et al., The impact of organic chemistry on process research and development, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 107-138
Authors:
Fu, XY
Citation: Xy. Fu, A commercial process for the synthesis of corticosteroid 9,11beta-epoxides, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 139-156
Authors:
Tao, JH
Guo, M
Tian, QP
Citation: Jh. Tao et al., Application of biocatalysis in the pharmaceutical industry, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 157-175
Authors:
Wu, ZP
Liu, J
Stirling, D
Citation: Zp. Wu et al., Determination of physicochemical properties in drug discovery and development, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 176-188
Authors:
Li, SH
Citation: Sh. Li, Advances in drug delivery and formulation technologies, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 189-201
Authors:
Chen, DH
Citation: Dh. Chen, Analytical chemistry in antisense oligonucleotide drug development, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 202-224
Authors:
Zhang, SH
Citation: Sh. Zhang, Therapeutic targets in the protein tyrosine phosphatase (PTP) super family: PTP1B antagonists for obesity and diabetes, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 225-244
Authors:
Xie, WL
Mercurio, F
Zhao, K
Citation: Wl. Xie et al., The ubiquitin-proteasome pathway: An emerging drug discovery target, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 245-255
Authors:
Zhou, ZS
Zhao, G
Wan, W
Citation: Zs. Zhou et al., Current developments in biological methylations, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 256-274
Authors:
Fan, JQ
Citation: Jq. Fan, Potential drug therapies for lysosomal storage disorders, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 275-291
Authors:
Yang, GXQ
Citation: Gxq. Yang, Therapeutic approaches to cocaine addiction, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 292-306
Authors:
Chen, SH
Citation: Sh. Chen, Synthesis and evaluation of L-Fd4C and related nucleoside analogs as novelantiviral agents, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 307-328
Authors:
Zhao, K
Reiner, J
Xie, WL
Citation: K. Zhao et al., FDA new drug approvals in 2000, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 329-349
Risultati:
1-19
|